Chloroquine and Primaquine (Aralen with Primaquine)

Category:

  • Antimalarial

Description:

  • Chloroquine and primaquine are used together in an oral preparation to prevent malaria.  Chloroquine and primaquine are both antimalarial agents; primaquine is added to cover for chloroquine-resistant strains of P. falciparum

Indications:

  • malaria prophylaxis

Contraindications:

  • Retinal field changes, porphyria

Precautions:

  • Pregnancy category C

  • Children, blood dyscrasias, severe GI disease, hepatic disease

  • G-6-PD deficiency, psoriasis, eczema

Adverse Reactions (Side Effects):

  • CNS: headache, fatigue, seizures, psychosis, stimulation

  • CV: asystole with syncope, heart block, ECG changes, hypotension

  • EENT: interference with visual accommodation

  • GI: anorexia, cramps, diarrhea, nausea, vomiting,

  • HEME: hemolytic anemia in G-6-PD deficient patients, leukopenia, methemoglobinemia in NADH methemoglobin reductase-deficient patients

  • SKIN: eczema, exfoliative dermatitis, skin eruptions, pruritus

Dosage:

Administered orally: available as tablets:  

  • chloroquine phosphate 500mg (300mg base)

  • primaquine phosphate 79mg (45mg base)

  • Marlaria prophylaxis: Adult:  PO 1 tablet taken at least 1 day prior to entering the endemic area, and then PO 1 tablet on the same day of each week throughout the stay and for 8 weeks after leaving an endemic area

 

 

Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300  

Gynecology and Obstetrics CD-ROM
Volumes 1-6
2004 Edition
Lippincott Williams & Wilkins
Copyright 2004
All Rights Reserved